Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
105.63
-0.86 (-0.81%)
Nov 5, 2024, 11:10 AM EST - Market open
Vaxcyte Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 147.5, with a low estimate of 129 and a high estimate of 163. The average target predicts an increase of 39.64% from the current stock price of 105.63.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 10, 2024.
Analyst Ratings
The average analyst rating for Vaxcyte stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $113 → $163 | Buy | Maintains | $113 → $163 | +54.31% | Sep 10, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $101 → $140 | Strong Buy | Maintains | $101 → $140 | +32.54% | Sep 4, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $106 → $153 | Buy | Maintains | $106 → $153 | +44.85% | Sep 3, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $108 → $129 | Strong Buy | Maintains | $108 → $129 | +22.12% | Sep 3, 2024 |
| Needham | Needham | Strong Buy Maintains $95 → $140 | Strong Buy | Maintains | $95 → $140 | +32.54% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.49
from -4.14
EPS Next Year
-4.95
from -4.49
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.98 | -4.00 | -4.24 | ||
| Avg | -4.49 | -4.95 | -4.95 | ||
| Low | -5.00 | -6.45 | -5.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.